X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

International Journal of Clinical Oncology

期刊標題檢索 INT J CLIN ONCO 最新評論: Hello, can I get your contact information? I ran into some problems w... (2023-11-09)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[International Journal of Clinical Oncology]您好,您是該頁面的第 34678 位訪客。

期刊簡介
期刊名稱International Journal of Clinical Oncology International Journal of Clinical Oncology
LetPub Score
6.2
50 ratings
Rate

Reputation
7.5

Influence
5.0

Speed
6.9

期刊簡稱INT J CLIN ONCOL
ISSN1341-9625
E-ISSN1437-7772
h-index53
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.800.9501.171
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Surgery
Q127 / 551
Category: Medicine
Subcategory: Hematology
Q131 / 137
Category: Medicine
Subcategory: Oncology
Q2102 / 404

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
官方網站https://www.springer.com/10147
在線稿件提交https://www.editorialmanager.com/ijco
開放訪問No
出版商Springer Singapore
主題領域医学
出版國/地區JAPAN
發行頻率隔月刊行
創刊年1996
每年文章數153每年文章數趨勢
黃金OA百分比20.93%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3193/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1341-9625%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【International Journal of Clinical Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326326
    CANCER RESEARCH310975
    BMC CANCER242836
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197881
    INTERNATIONAL JOURNAL OF CANCER188288
    Asian Pacific Journal of Cancer Prevention185743
    CLINICAL CANCER RESEARCH180962
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171670
    ONCOLOGY REPORTS171258
    CA-A CANCER JOURNAL FOR CLINICIANS163267
  •  

    International Journal of Clinical Oncology International Journal of Clinical Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [International Journal of Clinical Oncology] 的評論撰寫評論
作者: Yvette Strachey


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-09 08:12:52 評論於
Hello, can I get your contact information? I ran into some problems with the submission
(0) 讚! | Yvette Strachey

作者: 北风芊芊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 13:12:58 評論於
What does "pending approval" mean? Does anyone know what stage this is?
(0) 讚! | 北风芊芊

作者: Trista Isaiah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 20:40:01 評論於
Finally accepted
(0) 讚! | Trista Isaiah

作者: Trista Isaiah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-01 19:45:39 評論於
Reviews Completed for two months, still no results
(0) 讚! | Trista Isaiah

作者: 一条小凌柏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-10 10:56:32 評論於
What is the status of the submission now, it's been a few days
(0) 讚! | 一条小凌柏

作者: Trista Isaiah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-06 13:06:15 評論於
This magazine is too slow
(0) 讚! | Trista Isaiah

作者: 是你的笑丝呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-22 19:34:14 評論於
Could you please let me know how it turned out? I've also been assigned as an editor for a week now
(0) 讚! | 是你的笑丝呀

作者: 是你的笑丝呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-21 09:43:33 評論於
So long? This magazine is so slow, mine has also been assigned to the Editor for almost a week now
(0) 讚! | 是你的笑丝呀

作者: 啃你个猪头


領域: 医学
審稿時間: 5.0 month(s)
結果: 拒稿


撰寫評論

2023-03-27 15:21:13 評論於
I have been warned, and I feel that there is not much productivity in the editorial department. The submission speed is particularly slow, so I do not recommend submitting.
(0) 讚! | 啃你个猪头

作者: Sophia Connie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-01 12:19:18 評論於
Why hasn't my submission moved in 45 days? It's been sitting in the editor's hands the whole time
(0) 讚! | Sophia Connie

作者: 桃花静慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-16 23:52:56 評論於
I received an email invitation for submissions, is it an advertisement?
(0) 讚! | 桃花静慧

作者: Beverly Ferguson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-30 11:45:52 評論於
How have you been since then?
(0) 讚! | Beverly Ferguson

作者: 暴风三姗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-07 12:32:07 評論於
The author explains inside
(0) 讚! | 暴风三姗

作者: Miranda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-26 09:00:52 評論於
Boss, have you accepted it now?
(0) 讚! | Miranda

作者: Miranda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-22 23:58:24 評論於
I have also been working on several new submissions for days
(0) 讚! | Miranda

作者: 缠丝佳佳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-21 23:04:07 評論於
On August 10th, the submission was marked as "New Submission" for 8 days before being assigned to an editor; it has been 4 days since then and it is still "Editor Assigned"
(0) 讚! | 缠丝佳佳

作者: 缠丝佳佳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-16 08:43:49 評論於
13 days? I'm almost 6 days gone, will things change after that?
(0) 讚! | 缠丝佳佳

作者: 缠丝佳佳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-05 08:04:54 評論於
Oops, the international journal of oncology has been flagged
(0) 讚! | 缠丝佳佳

作者: 遛鸡摇


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2022-07-01 10:06:55 評論於
The translation of the given text into English is: "The speed is quite fast, no opinions given, the content is not suitable and instantly rejected."
(0) 讚! | 遛鸡摇

作者: 寒晴来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-21 15:48:10 評論於
How did it go? Brother
(0) 讚! | 寒晴来了

作者: 终幕德宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-06 16:44:57 評論於
The official website is available for download
(0) 讚! | 终幕德宇

作者: 终幕德宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-06 13:58:36 評論於
It took me one month to send it out
(0) 讚! | 终幕德宇

作者: 寒晴来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-05 17:29:37 評論於
Hey, bro, how long ago did you submit your new submission?
(0) 讚! | 寒晴来了

作者: 终幕德宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-05 16:26:58 評論於
How long will it take for reviewers to know the editor's decision, so anxious
(0) 讚! | 终幕德宇

作者: 寒晴来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-03 18:54:53 評論於
Did I make a mistake, the original warning from Jida First Hospital did not have this information, there is the International Journal of Oncology
(0) 讚! | 寒晴来了

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [International Journal of Clinical Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*